#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Niemann-Pick disease B precursor type acute leukaemia Chronic myeloid leukaemia Colitis ulcerative Sexually transmitted disease Epstein-Barr virus associated lymphoproliferative disorder Pulmonary hypertension HER2 mutant non-small cell lung cancer Hepatic angiosarcoma Erythema multiforme Hereditary ataxia Alpha-1 antitrypsin deficiency Vulval cancer Chorioretinitis Endocrine ophthalmopathy More trials…

    Learn about Rare Diseases

    Indolent systemic mastocytosis Marginal zone lymphoma Pulmonary fibrosis – Life with Disease Ewing’s sarcoma recurrent – Trials in Disease Angiosarcoma non-metastatic – Trials in Disease Lysosomal storage disorder – Trials in Disease Epidermolysis bullosa – Life with Disease Medulloblastoma – Diagnostics Retinoblastoma – Treatment Basal cell naevus syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    VANDETANIB Adct-402 Stx-241 Medroxyprogesterone Acetate VTX-002 Buloxibutid Tertomotide Paclitaxel Albumin-Bound Ropeginterferon Alfa-2B Hydralazine Hydrochloride Azathioprine Digoxin Immune Fab (Ovine) Pembrolizumab Avb-101 DAPIGLUTIDE Vudalimab Regn7508 Gad20-209-Fsp-A3 Zinc Acetate Dihydrate Taminadenant More therapies…

    Learn about Your Condition

    Arthroscopy Thymoma Mitral valve incompetence Tendon disorder HER2 negative breast cancer Graves' disease Endocarditis bacterial Type 1 diabetes mellitus Mitochondrial DNA depletion Giardiasis Sjogren's syndrome Obstructive pancreatitis Pyoderma gangrenosum Anxiety Cardiac ventricular thrombosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Hopital Saint Antoine

Hopital Saint Antoine

184 Rue Du Faubourg Saint Antoine, Paris, 75571, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study Comparing Integrase Inhibitor (Bictegravir) and Boosted Protease Inhibitor (Darunavir) Treatments for Patients with Advanced HIV Infection

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Bictegravir
    • Cobicistat
    • Darunavir
    Belgium France Germany Ireland Italy Spain

  • Study of Glofitamab and Obinutuzumab for Patients with Relapsed or Refractory Lymphomas After CAR T-cell Therapy

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Diffuse large B-cell lymphoma
    • Primary mediastinal large B-cell lymphoma
    • Mantle cell lymphoma
    Investigated Drugs:
    • Glofitamab
    • Obinutuzumab
    France

  • Study of Adagrasib and Cetuximab for Patients with Advanced Colorectal Cancer with KRAS G12C Mutation After First-Line Therapy

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Ramucirumab
    • Adagrasib
    • Aflibercept
    Austria Belgium Czechia Denmark Finland France +9

  • Study Comparing Relatlimab-Nivolumab Combination with Regorafenib or Trifluridine-Tipiracil for Patients with Advanced Metastatic Colorectal Cancer

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Tipiracil Hydrochloride
    • Trifluridine
    • Nivolumab
    Austria Belgium Czechia France Germany Italy +4

  • Study of Pembrolizumab, Trastuzumab, and Chemotherapy for Patients with HER2 Positive Advanced Stomach or Gastroesophageal Junction Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Adenocarcinoma gastric
    • Oesophageal adenocarcinoma
    Investigated Drugs:
    • Capecitabine
    • Cisplatin
    • Fluorouracil
    France Germany Ireland Italy Poland Spain

  • Study on Baricitinib for Hospitalized Patients with Severe or Critical COVID-19

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Lung disorder
    Investigated Drugs:
    • Baricitinib
    Austria Belgium Czechia France Germany Greece +8

  • Study on the Effectiveness and Safety of Bemcentinib for Hospitalized Patients with Moderate COVID-19

    Not recruiting

    2 1
    Investigated Diseases:
    • Lung disorder
    Investigated Drugs:
    • Bemcentinib
    Belgium Czechia France Greece Ireland Italy +4

  • Study on Adding Ipilimumab to Atezolizumab and Bevacizumab for Patients with Liver Cancer Receiving First-Line Treatment

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Hepatic cancer
    Investigated Drugs:
    • Atezolizumab
    • Bevacizumab
    • Ipilimumab
    France

  • Study on the Safety and Tolerability of A3907 for Adults with Primary Sclerosing Cholangitis (PSC)

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Cholangitis sclerosing
    Investigated Drugs:
    • A3907
    France Italy Poland Spain

  • Study on Botensilimab Alone and with Balstilimab or Drug Combination for Patients with Refractory Metastatic Colorectal Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Colon cancer metastatic
    Investigated Drugs:
    • Balstilimab
    • Botensilimab
    • Tipiracil
    Belgium France Italy Spain
Previous Page
1 … 12 13 14 15
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!